Heart failure is a debilitating and potentially life-threatening condition that affects millions of people worldwide. Despite significant advances in modern medicine, treatment options for heart failure remain limited. However, recent research has revealed promising new therapies that may improve cardiac function and quality of life for those suffering from this condition.
One of the most promising new approaches to treating heart failure is cellular-based therapy, which uses stem cells to promote tissue repair and regeneration. The SHOCK-HF trial, a clinical trial at Imperial College London in the United Kingdom, is exploring this therapy’s potential for treating ischemic heart failure.
The SHOCK-HF trial is using a combination of harmless sound energy and drugs to enhance stem cell homing, improving cardiac function and overall quality of life. One crucial aspect of the trial is the use of the QardioCore device to detect arrhythmias post-interventions. The QardioCore is a wearable ECG monitor that provides real-time patient heart rate and rhythm data, allowing researchers to assess the effectiveness and safety of the cellular-based therapy being tested in the trial.
The use of innovative technology like the QardioCore device highlights the importance of incorporating cutting-edge tools and techniques in medical research to improve patient outcomes. With continued advancements in cellular-based therapy and other promising therapies, there is hope for those suffering from heart failure. These breakthroughs offer a glimmer of hope for those who are struggling with this debilitating condition, giving them a chance at a better quality of life.
“Innovative technology like the QardioCore device underscores the importance of incorporating cutting-edge tools and techniques in medical research to improve patient outcomes.”
– Dr Salomon Narodden MB ChB, MSc DIC, MRCP(UK) MRCP(London), DIC PhD
Speak to one of our advisors to discover how QardioCore can help your clinic improve patient care, increase efficiency, and reduce healthcare costs. You can also learn more about how it is a valuable tool for those who want to monitor patients’ heart activity outside the clinic setting and provide more personalized care.
